Verastem (VSTM) Depreciation & Amortization - Total (2024 - 2025)
Verastem (VSTM) recorded quarterly Depreciation & Amortization - Total of $18000.0 in Q4 2025, up 800.0% quarter-over-quarter from $2000.0 in Q3 2025, and up 157.14% on a YoY basis from $7000.0 in Q4 2024.
Verastem (VSTM) Depreciation & Amortization - Total (2024 - 2025) Analysis & Trends
Verastem's Depreciation & Amortization - Total history runs 2 years deep, the most recent figure standing at $18000.0 for Q4 2025.
- In Q4 2025, Depreciation & Amortization - Total rose 157.14% year-over-year to $18000.0; the TTM figure through Mar 2026 stood at $20000.0 (down 31.03% YoY), while the FY2025 annual figure was $30000.0, up 15.38% from the prior year.
- Depreciation & Amortization - Total was $18000.0 for Q4 2025 at Verastem, up from $2000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization - Total ranged from a high of $18000.0 in Q4 2025 to a low of $2000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 6,000.00 |